Charles Newton

Charles Newton

Chief Financial OfficeratLyell Immunopharma· In proxies 2021–2023

Pay in FY2023+11% from the year before · Lyell Immunopharma stock -44.1% the same year

Charles Newton was paid $4.3M in FY2023 (Dec), up 11%. Lyell Immunopharma stock fell 44.1% that year.

Pay$100 in the stock at the end of FY21 → $25
Pay is from the Summary Compensation Table of each Lyell Immunopharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Lyell ImmunopharmaPublic company · 5 yr
    • Chief Financial Officer2021 – Present · 5 yrStock in role -97%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?